Risk scores provide an important contribution to clinical decision-making, but their validity has been questioned in patients with valvular heart disease (VHD), since current scores have been mainly derived and validated in adults undergoing coronary bypass surgery. The Working Group on Valvular Heart Disease of the European Society of Cardiology reviewed the performance of currently available scores when applied to VHD, in order to guide clinical practice and future development of new scores.
Introduction
The range of interventions available for the management of adults with valvular heart disease (VHD) is increasing. Risk assessment is required for optimal decision-making and should be specific to the individual patient, taking account of patient factors, clinical outcomes, and local resources. Risk stratification for adults with VHD in whom intervention is contemplated effects the decision to proceed as well as the timing and choice of procedure. This information enables the patient and family to participate in the management plan. Decision-making is particularly difficult in elderly patients who often have extensive comorbidity and differing expectations. Current risk scores are increasingly used to estimate the risk of valve surgery, define high-risk subgroups in which novel transcatheter techniques may be more appropriate, and adjudicate enrolment in clinical trials and registries. Beyond individual patients, risk scores are also increasingly used as a 'gold standard' to assess and compare outcomes between different populations, techniques, and medical centres. The recent VARC statement provides a standardized definition for endpoints after transcatheter aortic valve implantation, thus enabling a uniform assessment of outcome and future comparisons between different trials and devices. 1 In contrast, the present position paper provides clinical guidance for the general risk assessment of patients with VHD in whom intervention is being considered. The potential use of risk scores is discussed and the importance of the estimated in-hospital 30-day mortality is highlighted in this context. In this position statement, we summarize the strengths and weaknesses of currently available 'scores' used to estimate perioperative mortality following surgery in adults with VHD, and provide guidance for future development of new risk stratification methods.
Importance of risk assessment Individualized decision-making
Determination of the optimal timing of intervention (valve surgery or percutaneous procedures) in adults with VHD is based upon cumulative assessment of the natural history of the disease, the option of alternative treatments, the patient's life expectancy, risk of the intervention, and long-term post-procedural outcomes. While this decision-making process is generally based upon clinical experience, the availability of more objective means of risk assessment is desirable. Risk scores are increasingly used across the broad range of indications for cardiac surgery (including VHD), although most of them have been primarily defined and validated in patients undergoing coronary artery bypass surgery. However, more accurate risk prediction is needed as demand for therapeutic interventions increases, particularly in high-risk patients with VHD. The average older adult can be expected to live several years after effective intervention and estimation of risk can be adjusted to the individual patient based on comorbidity and functional evaluation. 2, 3 Average life expectancy according to age should be considered (Table 1) , but may be shorter in certain patients with valve disease, in particular in young patients, when compared with the normal population. 4 Decision-making in high-risk patients requires a team approach, including cardiologists, cardiac surgeons, and anaesthesiologists, especially when percutaneous techniques are being considered. 5 
Timing of surgery
There are several established Class I indications for surgery in patients with VHD, 6,7 although many patients are not referred promptly even when these indications are present. The reasons for this failure include misconceptions of the risk of intervention or a lack of knowledge of current guidelines. Late referral is frequently associated with higher surgical risk and may preclude intervention in some patients. Accurate risk assessment in these patients is critical for decision-making concerning the choice between valve surgery, transcatheter intervention, or medical therapy alone. Conversely, some patients may benefit from earlier elective intervention when the risk is low, despite minimal or absent symptoms. Clinical approaches are being explored to allow identification of patients at high risk of functional deterioration and those in whom delayed surgery may result in a higher operative risk or impaired long-term outcome. This decision-making depends on an accurate estimate of the operative risk for an individual patient in a specific centre.
Choice of procedure (conventional surgery vs. transcatheter techniques)
The development of transcatheter aortic valve implantation was fuelled by the fact that elderly patients with severe symptomatic aortic stenosis (AS) and significant comorbidity have high operative mortality and frequent postoperative complications following conventional surgery. As a result, about one-third of patients with symptomatic severe AS do not undergo surgery. 8 -10 Percutaneous techniques are currently recommended in patients in whom conventional valve surgery is contraindicated or poses very high risk. 5 The European System for Cardiac Operative Risk Evaluation (EuroSCORE) and the Society of Thoracic Surgery (STS) score have been used in several series to estimate the risk of conventional surgery, to determine a threshold for enrolment in clinical trials, and to justify the choice of new procedures in patients with a high estimated surgical risk. 11 -13 However, it is unclear whether their use can be extrapolated to predict the risk of percutaneous interventions. Risk assessment may also influence the choice of percutaneous approaches to mitral regurgitation, although experience in this field is very limited. Risk scores should be included in guidelines to identify high-risk patients who may benefit from additional work-up or alternative treatment. They may also be useful for administrative, logistic, and budget planning, especially when high-risk patients are identified.
Risk-benefit analysis
A score that predicts both in-hospital and long-term outcome will guide risk-benefit analysis and the choice of treatment. One therapy may have higher operative mortality but better long-term outcome (e.g. aortic valve replacement in a high-risk patient with AS), while an alternative option may have lower hospital mortality but less favourable or questionable long-term outcome (e.g. medical therapy or balloon valvuloplasty in the same patient). The risk-benefit analysis in a younger population will differ from that in an older population with more comorbidities.
Quality of care
Episodic evaluation of clinical outcomes in a given centre is an increasingly important part of quality control. The risk profile of patients may vary greatly between different institutions and this variation needs to be considered when outcome measures are compared. Standardization using risk scores allows comparison of the quality of care between institutions at national or international level and also between operators within a single institution. The availability of an accurate risk score for a specific patient population and procedure is also fundamental before the introduction of new technologies and their evaluation in relation to established techniques.
Risk scores
A number of risk scoring models for the prediction of perioperative mortality have been proposed. Most were initially developed and validated in large cohorts of patients, most of whom were undergoing coronary artery bypass surgery. The use of risk scores is recommended by the ESC guidelines 7 for decision-making in patients with VHD. The most widely used measure in the decision-making process is 30-day in-hospital mortality, although these risk scores also may be used for estimating the length of intensive care unit stay and overall costs as well as 1-year mortality.
The European system for Cardiac Operative Risk Evaluation (EuroSCORE)
The European System for Cardiac Operative Risk Evaluation (EuroSCORE) provides an estimate of in-hospital mortality following cardiac surgery 14 and was developed from a large database of patients undergoing cardiac surgery (mostly coronary surgery, 30% valve surgery) in 1995 15 with subsequent validation in Europe 16 and North America. 17 The additive EuroSCORE is calculated using simple mathematics, while the logistic EuroSCORE requires a computer. The additive EuroSCORE is calculated incrementally by adding risk points for 17 individual risk factors. However, the additive EuroSCORE has been shown to overpredict risk in contemporary coronary surgery and has poor predictive ability in high-risk patients. The logistic EuroSCORE (which uses a more complex algorithm based on the same variables) avoids some of these limitations and its use has been recommended, in particular for research studies. 18 Surgical techniques and results have improved since then and data collection for an updated version began in early 2010.
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The Society of Thoracic Surgeons' risk models (STS)
The US Society of Thoracic Surgeons (STS) risk model and calculator were developed to estimate the risk of mortality or serious postoperative complications following cardiac surgery and specifically consider the type of valve or coronary artery surgery. The current STS risk model includes a broad range of variables ( Table 2 ) making it the most detailed risk score available. The score is updated on a regular basis and can only be calculated via the STS website-it is thus important to specify and consider the date of calculation when applied for clinical purposes.
Ambler score
The first European risk model specifically dedicated to the prediction of in-hospital mortality in patients undergoing heart valve surgery (aortic and/or mitral) was proposed by Ambler et al. 20 in
2005. In contrast to the EuroSCORE, the Ambler score includes body mass index, need for dialysis, and the type of valve surgery. On the other hand, it does not take account of neurological dysfunction or previous cerebrovascular accident. The Ambler score is based upon a list of risk factors and a ready-reckoner table and is very quick and simple to calculate. Although not widely used, this tool is available through online medical information resources.
Other risk scores
Other risk models specifically designed for the prediction of in-hospital mortality after heart valve surgery have been proposed. 18,21 -25 Because of their limited dissemination in the scientific literature, these will not be addressed in further detail. Other risk scores have also been derived for heart surgery in general but not specifically validated in patients with VHD. 
Performance of risk scores validated in valvular heart disease
The EuroSCORE, the STS score, and the Ambler score have all been tested in large patient populations with VHD. Although their ability to predict perioperative morbidity 31 -33 and long-term outcome 34 has been reported, most published data refer to perioperative mortality.
Discrimination
The discriminatory power of a risk score refers to its ability to differentiate between low-and high-risk patients and is assessed using the area under the ROC curve or the c-index. 19, 35 Exact comparison of the discriminatory power of the different scores would require their validation in the same population. Such an analysis has not been performed to date. A meta-analysis assessing the utility of the logistic and additive EuroSCOREs in valve surgery reported an average area under the ROC curve of 0.72, 36 whereas a recent report of the STS found an area of 0.80 for isolated valve surgery 37 and of 0.75 for combined valve and coronary artery bypass surgery. 38 Similarly, the area under the curve for the Ambler score was 0.77. 20 
Calibration
Calibration refers to the comparison between predicted and observed mortality. 19 The logistic EuroSCORE tends to overestimate operative mortality, particularly in high-risk patients. 34,36,39 -43 One study compared the calibration of the additive and logistic EUROSCORE, the Ambler and STS risk scores in the same population of high-risk patients with AS. 39 In this group (who exceeded the 90th risk percentile), the risk of mortality was underestimated by the STS score and overestimated by the other two ( Table 3) . The discrepancy between these estimations of risk is illustrated by the predicted mortality using different risk scores for specific patients with a given risk profile ( Table 4) . The logistic EuroSCORE predicts the highest mortality in most cases. Furthermore, recent series demonstrate suboptimal performance of the additive 44, 45 and the logistic 44 -46 EuroSCORE in specific national populations.
In summary, the currently available scores achieve acceptable discrimination but sub-optimal calibration in estimating the operative mortality of contemporary heart valve surgery. 20 The heterogeneous nature of high-risk patients is another limitation. Given the number of possible comorbidities and their various combinations, it is difficult to accurately estimate the weight of each variable. Furthermore, most studies evaluating the predictive value of risk scores were performed in patients with AS. 42 Limited data are available for patients with mitral regurgitation, which is the second most common manifestation of VHD. In reality, treatment decisions for an individual patient relate to a specific centre (and specific surgeon) and it is therefore necessary to compare local outcomes to those predicted by a risk score. 48 Risk calculations can only be applied to a given patient population once the score is validated in this way-a strong argument in favour of regular audit, outcome assessment, and risk modelling for specific centres (and surgeons). 49 Variables affecting perioperative mortality and decision making in valvular heart disease Several studies have demonstrated the numerous potential predictors of operative mortality after heart valve surgery. 24,50 -53 Despite this large range of variables, a risk assessment model based on just three factors (age, left ventricular ejection fraction, and creatinine) provided better prognostic value than the additive and logistic EuroSCORE, Parsonnet, Cleveland, and Northern New England scores in one recent study. 54 Furthermore, use of a single variable (age) matched the ability of the additive and logistic Euro-SCORE to predict early mortality in a recent single centre analysis of patients undergoing isolated aortic valve replacement. 55 While these simpler predictors may be applicable to large populations, they are not necessarily useful discriminators when applied to individual patients. The ideal number of variables required to derive a risk score therefore deserves discussion. While a very limited number of variables may be sufficient to describe the risk of a certain population, a larger set of variables is needed to accurately predict the risk in an individual high-risk patient. 27 Clearly, a risk score should be accurate, reproducible, and practical, including a limited number of variables defined by the following characteristics:
1. Frequent representation in the derivation and validation cohorts to avoid inaccurate estimation of predictive power; 2. Easy and reproducible assessment; 3. Clinically relevant impact on operative mortality (but not surrogate endpoints).
The following variables fulfil these criteria: † Age; † Gender; † Symptomatic status (NYHA class); † Left ventricular ejection fraction; † Pulmonary artery systolic pressure; † Creatinine; † Chronic pulmonary disease; † Extracardiac arteriopathy (one or more of claudication, carotid occlusion or .50% stenosis, previous or planned intervention on the abdominal aorta, limb arteries, or carotids); † Neurological impairment affecting daily activity (disease severely affecting ambulation or day-to-day functioning); † Concomitant coronary artery disease; † Concomitant coronary artery bypass surgery; † Type of valve surgery (aortic, mitral, aortic + mitral, additional tricuspid, repair vs. replacement); † Concomitant surgery of the ascending aorta; † Redo cardiac surgery; † Emergency surgery.
While most variables are easily assessable, some (e.g. chronic pulmonary disease, renal disease) have a wide range of values with continuous impact on risk and need more accurate definition. The additive and logistic EuroSCORE inappropriately categorizes creatinine and pulmonary arterial systolic pressure in a binary fashion defined by an arbitrary threshold, although these variables should be considered in a continuous way.
Certain conditions may not be suitable for inclusion in risk scores since they do not fulfil these criteria. However, given their key importance, they should be considered in clinical decision-making.
1. Conditions that are relative or absolute contraindications to conventional surgery (and are therefore very rare in surgical series): † Severe calcification of the ascending aorta (porcelain aorta, preferably defined using standardized imaging criteria); † Previous chest wall radiation; 56 † Hepatic failure; † Chest wall malformation; Risk assessment in valvular heart disease
